Likelihood and predictors of ST-elevation in patients hospitalized for myocardial infarction

Ville Kytö1, Jussi Sipilä1, Päivi Rautava1

  • 1Heart Center, Division of Clinical Neurosciences, Neurology and Clinical Research Center, Turku University Hospital, Turku, Finland; PET Center, Medicine, Neurology and Public Health, University of Turku, Turku, Finland.

Plos One
|September 26, 2014
PubMed

Insights

ST-elevation myocardial infarction (STEMI) is less common in older adults and women. Conditions like diabetes and renal insufficiency are linked to non-ST-elevation myocardial infarction (NSTEMI).

Area of Science:

  • Cardiology and Cardiovascular Research
  • Public Health and Epidemiology
  • Medical Diagnostics

Background:

  • Emergency treatment for myocardial infarction (MI) depends on ST-elevation presence.
  • Understanding ST-elevation MI (STEMI) prevalence and associated factors is crucial but limited across diverse populations.

Purpose of the Study:

  • To investigate the likelihood of ST-elevation in myocardial infarction (MI).
  • To identify patient characteristics associated with ST-elevation in MI.

Main Methods:

  • A nationwide registry study encompassing 68,162 patients aged 30+ with MI.
  • Data collected from 22 Finnish hospitals with angiolaboratory services over eight years.
  • Analysis focused on the likelihood and patient features associated with ST-elevation.

Main Results:

  • ST-elevation MI (STEMI) occurred in 37.5% of patients; non-STEMI in 62.5%.
  • STEMI prevalence decreased significantly with age, particularly in octogenarians (24.7%).
  • Men showed a higher relative risk for STEMI (13%) compared to women, with differences diminishing in older age groups. Conditions like diabetes, atrial fibrillation, and renal insufficiency were linked to non-STEMI.

Conclusions:

  • ST-elevation in MI is more common in men and decreases with advancing age.
  • Specific comorbidities (diabetes, atrial fibrillation, renal insufficiency, etc.) are associated with the absence of ST-elevation.
  • These findings can aid in predicting the likelihood of ST-elevation in MI patients, potentially guiding treatment decisions.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.9K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
492
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
811
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
488
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
514